Clinical trials
Leukemia, Mast-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 8 |
| 2010 | 3 |
| 2011 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
| Terminated | 7 |
| Withdrawn | 5 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Unknown status | 2 |
| Available | 1 |
| Not yet recruiting | 1 |
| No longer available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 6 |
| Blueprint Medicines Corporation | 5 |
| M.D. Anderson Cancer Center | 4 |
| Wake Forest University Health Sciences | 4 |
| Jason Robert Gotlib | 3 |
| National Cancer Institute (NCI) | 3 |
| Novartis Pharmaceuticals | 3 |
| UNC Lineberger Comprehensive Cancer Center | 3 |
| Asan Medical Center | 2 |
| Case Comprehensive Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Mast-Cell | 60 |
| Leukemia, Biphenotypic, Acute | 41 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 41 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 38 |
| Leukemia, Myeloid, Acute | 37 |
| Leukemia, Hairy Cell | 36 |
| Leukemia, Large Granular Lymphocytic | 36 |
| Leukemia, Myelomonocytic, Chronic | 35 |
| Burkitt Lymphoma | 34 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 33 |
Trials
Showing 26 to 50 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.